Legend Biotech Corp. (LEGN) PT Lowered to $78 at Barclays

August 12, 2026 5:26 AM

Barclays analyst Gena Wang lowered the price target on Legend Biotech Corp. (NASDAQ: LEGN) to $78.00 (from $80.00) while maintaining a Overweight rating.

No results found